15.09
price down icon0.98%   -0.15
 
loading
前日終値:
$15.24
開ける:
$15.27
24時間の取引高:
588.56K
Relative Volume:
0.70
時価総額:
$1.30B
収益:
$17.49M
当期純損益:
$-78.50M
株価収益率:
-12.58
EPS:
-1.2
ネットキャッシュフロー:
$-52.85M
1週間 パフォーマンス:
-0.20%
1か月 パフォーマンス:
-1.76%
6か月 パフォーマンス:
+50.75%
1年 パフォーマンス:
+2.31%
1日の値動き範囲:
Value
$14.93
$15.59
1週間の範囲:
Value
$14.84
$15.86
52週間の値動き範囲:
Value
$8.26
$16.81

Liquidia Corp Stock (LQDA) Company Profile

Name
名前
Liquidia Corp
Name
セクター
Healthcare (1166)
Name
電話
919.328.4400
Name
住所
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Name
職員
0
Name
Twitter
@Liquidia_Inc
Name
次回の収益日
2025-03-19
Name
最新のSEC提出書
Name
LQDA's Discussions on Twitter

LQDA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
LQDA
Liquidia Corp
15.09 1.30B 17.49M -78.50M -52.85M -1.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

Liquidia Corp Stock (LQDA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-20 開始されました Wells Fargo Overweight
2024-10-16 開始されました Scotiabank Sector Outperform
2024-08-19 アップグレード Raymond James Outperform → Strong Buy
2024-08-16 開始されました Raymond James Outperform
2024-06-25 開始されました Oppenheimer Perform
2024-01-05 繰り返されました Needham Buy
2022-09-19 再開されました Wedbush Underperform
2022-09-01 ダウングレード Wedbush Neutral → Underperform
2022-07-22 開始されました Ladenburg Thalmann Buy
2022-05-31 開始されました BTIG Research Buy
2022-05-26 開始されました BofA Securities Buy
2020-12-04 開始されました H.C. Wainwright Buy
2020-11-20 ダウングレード Wedbush Outperform → Neutral
2018-11-08 再開されました Jefferies Buy
2018-09-05 開始されました Wedbush Outperform
2018-08-20 開始されました Jefferies Buy
2018-08-20 開始されました Needham Buy
すべてを表示

Liquidia Corp (LQDA) 最新ニュース

pulisher
Mar 28, 2025

Liquidia stock rises as Yutrepia undergoes FDA review (LQDA) - Seeking Alpha

Mar 28, 2025
pulisher
Mar 28, 2025

FDA accepts Liquidia’s resubmission for YUTREPIA inhalation powder - Investing.com

Mar 28, 2025
pulisher
Mar 28, 2025

Liquidia announces FDA acceptance of NDA resubmission for YUTREPIA - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder - Yahoo Finance

Mar 28, 2025
pulisher
Mar 27, 2025

Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference - The Manila Times

Mar 27, 2025
pulisher
Mar 23, 2025

Liquidia Corporation (NASDAQ:LQDA) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 23, 2025
pulisher
Mar 23, 2025

Liquidia (NASDAQ:LQDA) Price Target Raised to $34.00 - Defense World

Mar 23, 2025
pulisher
Mar 21, 2025

Earnings To Watch: Liquidia Corp (LQDA) Reports Q4 2024 Result - GuruFocus.com

Mar 21, 2025
pulisher
Mar 21, 2025

Scotiabank raises Liquidia stock target to $34 on Yutrepia prospects By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 20, 2025

What 4 Analyst Ratings Have To Say About Liquidia - Benzinga

Mar 20, 2025
pulisher
Mar 20, 2025

Scotiabank raises Liquidia stock target to $34 on Yutrepia prospects - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Tesla To $450? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga

Mar 20, 2025
pulisher
Mar 20, 2025

Raymond James maintains strong buy on Liquidia stock, $27 target - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

H.C. Wainwright maintains Buy on Liquidia stock, $29 target - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Raymond James maintains strong buy on Liquidia stock, $27 target By Investing.com - Investing.com UK

Mar 20, 2025
pulisher
Mar 20, 2025

Liquidia Full Year 2024 Earnings: Misses Expectations - Yahoo Finance

Mar 20, 2025
pulisher
Mar 20, 2025

Beyond the Balance Sheet: What SWOT Reveals About Liquidia Corp (LQDA) - GuruFocus.com

Mar 20, 2025
pulisher
Mar 19, 2025

Earnings call transcript: Liquidia Technologies Q4 2024 misses revenue forecast - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Liquidia Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 19, 2025
pulisher
Mar 19, 2025

Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 19, 2025
pulisher
Mar 19, 2025

Liquidia Corp Reports Annual EPS of -$1.66 and Revenue of $14.0 Million, Missing Estimates - GuruFocus.com

Mar 19, 2025
pulisher
Mar 19, 2025

Liquidia Corp SEC 10-K Report - TradingView

Mar 19, 2025
pulisher
Mar 19, 2025

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update - TradingView

Mar 19, 2025
pulisher
Mar 18, 2025

Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million - The Manila Times

Mar 18, 2025
pulisher
Mar 18, 2025

Liquidia Lands Massive $100M Funding Deal: YUTREPIA Commercial Launch Gets Major Boost - StockTitan

Mar 18, 2025
pulisher
Mar 14, 2025

When Will Liquidia Corporation (NASDAQ:LQDA) Become Profitable? - Simply Wall St

Mar 14, 2025
pulisher
Mar 13, 2025

Commit To Buy Liquidia At $7.50, Earn 11.3% Using Options - Nasdaq

Mar 13, 2025
pulisher
Mar 12, 2025

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025 - The Manila Times

Mar 12, 2025
pulisher
Mar 12, 2025

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025 - GlobeNewswire Inc.

Mar 12, 2025
pulisher
Mar 12, 2025

Rare Disease Biotech Liquidia Schedules Critical 2024 Financial Review - StockTitan

Mar 12, 2025
pulisher
Mar 11, 2025

Insider Sell: CFO and COO Michael Kaseta Sells 12,166 Shares of Liquidia Corp (LQDA) - GuruFocus.com

Mar 11, 2025
pulisher
Mar 05, 2025

Liquidia’s chief commercial officer sells shares worth $9,146 By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 04, 2025

Liquidia’s chief commercial officer sells shares worth $9,146 - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Liquidia Corp CFO Michael Kaseta sells shares worth $13,503 - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Liquidia Corp Executives Sell Shares - TradingView

Mar 04, 2025
pulisher
Feb 28, 2025

FDA Was Right to Delay Approving Liquidia's Yutrepia, Judge Says - Bloomberg Law

Feb 28, 2025
pulisher
Feb 28, 2025

Liquidia Corp loses FDA lawsuit; Tyvaso DPI exclusivity stands - Investing.com

Feb 28, 2025
pulisher
Feb 27, 2025

Liquidia Challenge To UTC's Tyvaso Exclusivity Fails - Law360

Feb 27, 2025
pulisher
Feb 12, 2025

Bleakley Financial Group LLC Lowers Stock Position in Liquidia Co. (NASDAQ:LQDA) - Defense World

Feb 12, 2025
pulisher
Feb 10, 2025

The Attractiveness of Investing In Liquidia Corp (LQDA) is Growing - Knox Daily

Feb 10, 2025
pulisher
Feb 10, 2025

Analysts Set Liquidia Co. (NASDAQ:LQDA) Target Price at $25.38 - Armenian Reporter

Feb 10, 2025
pulisher
Feb 08, 2025

Liquidia Co. (NASDAQ:LQDA) Receives $25.38 Average Price Target from Brokerages - MarketBeat

Feb 08, 2025
pulisher
Feb 08, 2025

Liquidia Corp's chief business officer sells $6,319 in stock - MSN

Feb 08, 2025
pulisher
Feb 07, 2025

Life Sciences Group Of The Year: Cooley - Law360

Feb 07, 2025
pulisher
Feb 06, 2025

Stock Performance Spotlight: Liquidia Corp (LQDA) Ends the Day at 15.74, Up by 3.89 - The Dwinnex

Feb 06, 2025
pulisher
Feb 06, 2025

Liquidia Corp.: We Have Exposure To The Upside Now - Seeking Alpha

Feb 06, 2025
pulisher
Feb 06, 2025

Liquidia Corp (LQDA) stock on the rise: An overview - US Post News

Feb 06, 2025
pulisher
Feb 05, 2025

Arquitos Capital Management Q4 2024 Commentary - Seeking Alpha

Feb 05, 2025
pulisher
Feb 04, 2025

This trade activity should not be overlooked: Liquidia Corp (LQDA) - SETE News

Feb 04, 2025
pulisher
Feb 04, 2025

Liquidia Corp [LQDA] Investment Appeal on the Rise - Knox Daily

Feb 04, 2025
pulisher
Jan 31, 2025

Liquidia Corporation's Long-Running Saga Is Coming To An End (NASDAQ:LQDA) - Seeking Alpha

Jan 31, 2025

Liquidia Corp (LQDA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Liquidia Corp (LQDA) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Moomaw Scott
Chief Commercial Officer
Mar 03 '25
Sale
15.45
592
9,146
218,150
Kaseta Michael
CFO and COO
Mar 03 '25
Sale
15.45
874
13,503
404,598
Adair Jason
Chief Business Officer
Mar 03 '25
Sale
15.45
451
6,968
182,254
Adair Jason
Chief Business Officer
Jan 27 '25
Sale
14.20
445
6,319
179,770
Saggar Rajeev
Chief Medical Officer
Jan 21 '25
Sale
13.00
2,445
31,785
267,943
Schundler Russell
General Counsel
Jan 14 '25
Sale
11.78
16,393
193,110
573,478
Saggar Rajeev
Chief Medical Officer
Jan 14 '25
Sale
11.78
6,249
73,613
270,388
Moomaw Scott
Chief Commercial Officer
Jan 14 '25
Sale
11.78
8,362
98,504
215,494
Kaseta Michael
CFO and COO
Jan 14 '25
Sale
11.78
23,370
275,299
401,755
Adair Jason
Chief Business Officer
Jan 14 '25
Sale
11.78
4,809
56,650
180,215
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
大文字化:     |  ボリューム (24 時間):